Malvina Hoxha Catholic University Our Lady of Good Counsel Tirana Albania
Dr. Hoxha is a researcher and lecturer of pharmacology at the Catholic University ‘Our Lady of Good
Counsel’, Tirana, Albania. She graduated in pharmacy (Summa cum Laude), and obtained her PhD in
pharmacology at the Department of Pharmacological and Biomolecular Sciences, University of Milan.
Her area of research is focused mainly on arachidonic acid metabolites and their role in different in-
flammatory diseases. Dr. Hoxha attended a post-doctorate at the University of Granada, Spain, and
recently she obtained a research award from the Austrian Academy of Science. In 2019, she was elected as a national delegate
of the ERS (European Respiratory Society).
Aristeidis H. Katsanos McMaster University Hamilton, ON Canada
Aristeidis H. Katsanos, MD, Ph.D., is currently a clinical fellow in stroke medicine at the McMaster
University, Hamilton, Ontario, Canada. He received his graduate and post-graduate degrees from the
University of Ioannina School of Medicine, Greece. His research focuses on the evidence-based evalu-
ation of emerging diagnostic and therapeutic approaches to acute stroke treatment and secondary
stroke prevention. He has a particular enthusiasm for epidemiology, biostatistics and meta-research. He
has actively participated in numerous research projects and international collaborations and has published more than 140 papers
in high-impact medical journals, indexed in PubMed, which according to Google Scholar, have received more than 1981 cita-
tions (H-index 26), to date.
Hari S. Sharma Uppsala University Uppsala Sweden
Dr. Hari Shanker Sharma obtained his PhD in 1982 from Banaras Hindu University and Dr Med Sci in 1999 from Uppsala University and engaged in Neuroscience research over 40 years. He is currently the Director of Research International Experimental CNS Injury & Repair (IECNSIR) based at Uppsala University. He authored more than 250 original research papers and Edited several Books in Progress in Brain Research Series and International Review of Neurobiology series. His current research includes Nano delivery of drugs to treat CNS injury and enhance neurorepair.
Cesar V. Borlongan Department of Neurosurgery and Brain Repair University of South Florida Morsani College of Medicine Tampa, FL USA
CESAR V. BORLONGAN, Distinguished Professor, Vice-Chairman for Research, and Director of USF Morsani College of Medicine’s Center of Excellence for Aging and Brain Repair. His highly innovative translational “bench to clinic” research has led to FDA-approved clinical trials of cell transplantation in CNS disorders. He is an author of >370 peer-reviewed publications. He is funded by and a regular reviewer for NIH, DOD, and VA. He was the President-Elect of American Society for Neural Therapy and Repair, and International Placenta Stem Cell Society, and is an elected Fellow of AAAS and AIMBE. He was featured in The Lancet in 2008.